Biological Materials Lab, CSIR-Central Leather Research Institute, Chennai 600020, Tamilnadu, India.
Biological Materials Lab, CSIR-Central Leather Research Institute, Chennai 600020, Tamilnadu, India.
Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:455-464. doi: 10.1016/j.msec.2018.08.026. Epub 2018 Aug 9.
The prolonged inflammation and elevation of Matrix Metalloproteniases (MMPs) at the wound site causes significant degradation of Extracellular matrix (ECM) which cause delays the process of wound healing. Hence the development of therapeutic dressing matrices to control and to positively regulate MMPs balance was considered important in achieving faster healing. The design of biomaterial matrices of collagen scaffold has the challenge to mimic the function of ECM and emulate to the attraction of fibroblast migration at wound site. Herein, we report the fabricated Collagen (COL) matrices impregnated with Siderophore loaded Gelatin Microspheres (SGM) as a delivery system to control both infection and protease levels in the wound site for accelerated healing. The fabricated collagen scaffold impregnated with siderophore loaded gelatin microspheres (COL-SGM) was characterized physiochemically using Fourier transform infrared spectroscopy (FTIR), Scanning electron microscopy (SEM) and swelling behaviour. The COL-SGM scaffold possesses good swelling ability and also exhibited better morphology for the cell adhesion and proliferation. The in vitro biocompatibility and in vitro fluorescence activity of the developed scaffold revealed to possess good cell proliferation and migration against NIH 3T3 fibroblast and Human keratinocytes (HaCaT) cell lines. Furthermore, the in vivo evaluation offered the advantage of neutralizing the excessive proteases and delivered the siderophore in controlled fashion depending on the level of wound exudates with modulated MMPs. Moreover, the COL-SGM scaffold exhibited with increase in the collagen synthesis and faster reepitheliazation of wounds. Thus the developed COL-SGM scaffold achieved improvements in biocompatibility and act as a potent MMP inhibitor to improve wound healing efficiency in tissue engineering application.
在伤口部位,基质金属蛋白酶(MMPs)的长期炎症和升高会导致细胞外基质(ECM)的大量降解,从而延迟伤口愈合过程。因此,开发治疗性敷料基质来控制和积极调节 MMPs 平衡被认为是实现更快愈合的重要手段。胶原支架生物材料基质的设计面临着模仿 ECM 功能并模拟成纤维细胞在伤口部位迁移吸引力的挑战。在这里,我们报告了载铁载体明胶微球(SGM)的胶原(COL)基质的制备,作为一种递送系统来控制伤口部位的感染和蛋白酶水平,以加速愈合。用傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)和溶胀行为对载铁载体明胶微球(COL-SGM)浸渍的胶原支架进行了物理化学特性表征。COL-SGM 支架具有良好的溶胀能力,并且对细胞粘附和增殖表现出更好的形态。开发的支架的体外生物相容性和体外荧光活性表明,对 NIH 3T3 成纤维细胞和人角质形成细胞(HaCaT)细胞系具有良好的细胞增殖和迁移能力。此外,体内评估提供了中和过量蛋白酶的优势,并根据伤口渗出物的水平以受控方式递送铁载体,同时调节 MMPs。此外,COL-SGM 支架表现出胶原蛋白合成增加和伤口更快的再上皮化。因此,开发的 COL-SGM 支架提高了生物相容性,并作为一种有效的 MMP 抑制剂,提高了组织工程应用中的伤口愈合效率。